GLP-1 receptor agonistssuch as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound)work by mimicking hormones that regulate blood sugar, appetite, and digestion
It is a triple agonist, meaning that it mimics three different hormones GLP-1, GIP, and glucagon to reduce appetite, manage blood sugar, and increase metabolism and fat breakdown in the body
Tuy nhin, nu gn n gi ung liu k tip, hy b qua liu qun v tip tc theo lch trnh bnh thng
Martin, B., Lopez de Maturana, R., Brenneman, R., Walent, T., Mattson, M
Dosis orientativa: 500 mg2 g/da (segn objetivo, tipo de L-carnitina y nivel de actividad)
For semaglutide, for example, the initial dose is typically 0.25 mg once a week for the first 4 weeks